UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	December 1, 2016

Accession Number:	0001104659-16-159299
Submission Type:	POS AM
CIK: 0001557746 Company Name: Aclaris Therapeutics, Inc. File Number: 333-212095